icosapent ethyl / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 26 Diseases   7 Trials   7 Trials   4331 News 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
icosapent ethyl / Generic mfg.
2005-002088-98: Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease

 
3
100
Europe
Ethyl-EPA, LAX-101,
Amarin Neuroscience Ltd, AMARIN NEUROSCIENCE LTD
HUNTINGTON’S DISEASE
 
 
NCT04239950: Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Active, not recruiting
3
300
RoW
Placebo, Ethyl Icosapentate
Mochida Pharmaceutical Company, Ltd., Sumitomo Pharma (Suzhou) Co., Ltd.
Hypertriglyceridemia
12/23
12/23
EMT2, NCT03428477 / 2016-000628-24: EPA for Metastasis Trial 2

Active, not recruiting
3
418
Europe
Icosapent Ethyl, Vascepa, Placebo
Mark A Hull, PhD FRCP, Yorkshire Cancer Research, Amarin Pharma Inc.
Liver Metastasis, Colon Cancer
11/25
04/26

Download Options